Medical News

RSS

Fabrinet second quarter total revenue increases 73.3% to $167.4 million

Fabrinet, a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced its financial results for the second quarter of fiscal 2013 ended December 28, 2012.

5 Feb 2013

Adequate vitamin D levels during young adulthood may reduce risk of type 1 diabetes

Having adequate levels of vitamin D during young adulthood may reduce the risk of adult-onset type 1 diabetes by as much as 50%, according to researchers at Harvard School of Public Health (HSPH).

5 Feb 2013

St. Jude Medical initiates Portico Transfemoral European Trial in severe aortic stenosis

St. Jude Medical, Inc., a global medical device company, today announced the first patient implant of its 25 mm Portico Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial.

5 Feb 2013

Immune system can use melanoma's own proteins to kill off cancer cells

Though a small group of proteins, the family called Ras controls a large number of cellular functions, including cell growth, differentiation, and survival. And because the protein has a hand in cellular division, mutated Ras, which can be detected in one-third of all tumors, contributes to many human cancers by allowing for the rapid growth of diseased cells.

5 Feb 2013

AIBioTech announces implementation of L-asparaginase activity assay for pediatric ALL

AIBioTech is pleased to announce implementation of a new laboratory derived test to measure L-asparaginase levels in patients being treated with any of the current asparaginase drugs including: Oncaspar, Kidrolase, Erwinaze, and Elspar.

5 Feb 2013

Researchers identify gene variants that influence lifespan

By broadly comparing the DNA of children to that of elderly people, gene researchers have identified gene variants that influence lifespan, either by raising disease risk or by providing protection from disease.

5 Feb 2013

FDA clears Ethicon Endo-Surgery’s ENSEAL G2 Articulating Tissue Sealer

To address surgeons' need for strong sealing in tight spaces where access is limited, Ethicon Endo-Surgery, Inc. (Ethicon) today announces the 510(k) clearance from the U.S. Food and Drug Administration for the ENSEAL G2 Articulating Tissue Sealer.

5 Feb 2013

Synageva announces 12-week data from sebelipase alfa Phase I/II study on LAL Deficiency

Synageva BioPharma Corp. (Synageva), a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, today announced publication of the 12-week Phase I/II extension study data of sebelipase alfa in adults with lysosomal acid lipase deficiency (LAL Deficiency) in the online version and an upcoming print edition of Hepatology

5 Feb 2013

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

Gilead Sciences, Inc. announced today its results of operations for the fourth quarter and full year 2012.

5 Feb 2013

Technion, Alpha Szenszor partner to commercialize lung cancer diagnostics

Alpha Szenszor Inc., a leading provider of carbon nanotube based sensors and the Technion -Israel Institute of Technology have announced a joint venture for the commercialization of advanced lung cancer diagnostics based on Volatile Organic Compound (VOC) detection from human breath.

5 Feb 2013

Agilent launches new application compendiums on designer drug testing and toxicology of oral fluids

Agilent Technologies Inc. today introduced new application compendiums on designer drug testing and toxicology of oral fluids.

5 Feb 2013

BrainStorm initiates NurOwn Phase IIa dose-escalating trial in ALS

BrainStorm Cell Therapeutics, a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the first patient began treatment in the Company's Phase IIa dose-escalating clinical trial for ALS.

5 Feb 2013

GVK Biosciences extends GOBIOM license to Biomarker Qualification Group of US FDA

GVK Biosciences (GVK BIO) today announced that it is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug Administration (US FDA).

5 Feb 2013

Topline results from Gilead’s FISSION and NEUTRINO Phase 3 studies on HCV infection

Gilead Sciences today announced topline results from two Phase 3 studies, FISSION and NEUTRINO, evaluating a 12-week course of the once-daily nucleotide sofosbuvir in combination with ribavirin (FISSION) and in combination with ribavirin and pegylated interferon (NEUTRINO) among treatment-naïve patients with chronic hepatitis C virus (HCV) infection.

5 Feb 2013

Luminex consolidated fourth quarter revenue increases 16% to $55.5 million

Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2012.

From Luminex 4 Feb 2013

Survey: 62% of newly graduated nurses will have trouble finding jobs in the next year

62% of newly graduated nurses will have trouble finding jobs in the next year, according to a survey conducted by Nursing Degree.org, a leading nursing education and career portal. The study surveyed Registered Nurses who had graduated in the last two years. Most of the students surveyed indicated that they had trouble finding a full time job in their field, or were not working in the field of nursing at all, despite their qualifications.

4 Feb 2013

FDA approves K7 LLC's K7C Cervical Spacer for use as IBF device

K7 LLC's K7C Cervical Spacer, a spinal implant device using Evonik's VESTAKEEP PEEK (polyetheretherketone), has received the U.S. Food and Drug Administration's (FDA) 510(k) approval for use as an Intervertebral Body Fusion (IBF) device.

4 Feb 2013

Perceived work-related stress in midlife predicts functional limitations and disability later in old age

Nearly 30% of adult workers suffer from work-related stress, and it is commonly acknowledged that stress has damaging effects on individual's health. Recently published prospective cohort study by Dr. Jenni Kulmala and co-workers from the Gerontology Research Center (GEREC) at the University of Jyväskylä, Finland, provides strong evidence that perceived work-related stress in midlife predicts functional limitations and disability later in old age.

4 Feb 2013

ZirMed releases Clinical Link for healthcare providers

ZirMed, Inc. announces the release of a secure, national information exchange for healthcare providers. The innovative solution, called ZirMed Clinical Link harnesses the power of ZirMed's connected network of healthcare providers facilitating secure provider-to-provider communications from any EMR or information management system via ZirMed's software-as-a-service (SaaS) platform.

4 Feb 2013

Chem-Aqua, Nephros partner to distribute new ultrafilters in North America

Nephros, Inc. and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America.

4 Feb 2013

Medical News

Fabrinet second quarter total revenue increases 73.3% to $167.4 million

Adequate vitamin D levels during young adulthood may reduce risk of type 1 diabetes

St. Jude Medical initiates Portico Transfemoral European Trial in severe aortic stenosis

Immune system can use melanoma's own proteins to kill off cancer cells

AIBioTech announces implementation of L-asparaginase activity assay for pediatric ALL

Researchers identify gene variants that influence lifespan

FDA clears Ethicon Endo-Surgery’s ENSEAL G2 Articulating Tissue Sealer

Synageva announces 12-week data from sebelipase alfa Phase I/II study on LAL Deficiency

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

Technion, Alpha Szenszor partner to commercialize lung cancer diagnostics

Agilent launches new application compendiums on designer drug testing and toxicology of oral fluids

BrainStorm initiates NurOwn Phase IIa dose-escalating trial in ALS

GVK Biosciences extends GOBIOM license to Biomarker Qualification Group of US FDA

Topline results from Gilead’s FISSION and NEUTRINO Phase 3 studies on HCV infection

Luminex consolidated fourth quarter revenue increases 16% to $55.5 million

Survey: 62% of newly graduated nurses will have trouble finding jobs in the next year

FDA approves K7 LLC's K7C Cervical Spacer for use as IBF device

Perceived work-related stress in midlife predicts functional limitations and disability later in old age

ZirMed releases Clinical Link for healthcare providers

Chem-Aqua, Nephros partner to distribute new ultrafilters in North America

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News